Ostomycure AS is a medical technology company, developing an innovative new solution for evacuating of fluids from the intestines. The technology is called Transcutaneous Evacuation Implant Technology, TIES®. The TIES technology is aimed to be an alternative for patients with inflammatory conditions in colon, cancer in the urinary bladder and cancer in rectum.

Ostomycure has just entered the clinical trial phase. In the pre-clinical phase Ostomycure showed, as the first company ever, that it is possible to get a good in-growth between intestine and a titanium implant.

Ostomycure is based at Oslo Innovation Centre in Oslo, Norway and is collaborating with Ahus Hospital in Akershus, Norway, Karolinska University Hospital, Huddinge, Sweden, Rikshospitalet in Oslo, Norway, Norrlands University Hospital in Umeå, Sweden and a number of service providers.